News
-
Cannabis pain queries
Tuesday | Sep 25 2018NEW research analysing existing data relating to cannabinoid drugs for pain relief has found they may prevent the onset of pain by increasing pain thresholds, but may not actually reduce the intensity of pre-existing pain or help people who are hyper-sensitive to pain.
-
Psychotropics tool
Tuesday | Sep 25 2018IN THE face of mainstream media highlighting the plight of nursing home residents being plied with excess doses of psychotropics to control their behaviour, two research pharmacists and a research nurse have developed a tool to assist.
-
Dispensary Corner
Tuesday | Sep 25 2018
25 Sep 18AMERICAN life insurance company John Hancock has begun offering its life insurance policy holders incentives to be healthier including a reduction in premiums if they wear a fitness tracker.
-
-
New Teva program goes live
Monday | Sep 24 2018COMMUNITY pharmacies are being invited to participate in a new Teva Wake Patient Program conducted in partnership with PharmaPrograms, providing opportunities for additional professional services income.
-
Consumers pro Amazon Rx
Monday | Sep 24 2018MORE than 70% of Amazon customers in the United States would be willing to purchase prescription drugs through the online retailer, according to the results of a new survey carried out by German investment bank Deutsche Bank.
-
Hunt flags Guild anniversary
Monday | Sep 24 2018HEALTH Minister Greg Hunt has helped mark the 90th anniversary of the Pharmacy Guild of Australia, by giving the organisation the Australian flag which was displayed in the House of Representatives on 20 Aug 2018 - exactly 90 years since the first ever meeting of the Guild's National Council in 1928.
-
ThinOPTICS prize
Monday | Sep 24 2018THIS week ThinOPTICS has partnered with Pharmacy Daily to give away daily prizes of the company's new "take everywhere" reading glasses which are also available for pharmacies to stock.
-
H.Pylori ups bleed risk
Monday | Sep 24 2018THE presence of common stomach bacterium helicobacter pylori (pictured) can more than double the risk of upper gastrointestinal (UGI) bleeding in patients taking daily low-dose aspirin, according to a meta-analysis published online by the Medical Journal of Australia.
-
Ilumya approval
Monday | Sep 24 2018MUMBAI-BASED Sun Pharmaceutical Industries has welcomed approval by the Therapeutic Goods Administration of its Ilumya (tildrakizumab) for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy.
